Epidemiology of Respiratory Syncytial Virus Hospitalizations in Poland: An Analysis from 2015 to 2023 Covering the Entire Polish Population of Children Aged under Five Years.
Jan Mazela, Teresa Jackowska, Marcin Czech, Ewa Helwich, Oliver Martyn, Pawel Aleksiejuk, Anna Smaga, Joanna Glazewska, Jacek Wysocki
Author Information
Jan Mazela: Department of Neonatology, Poznan University of Medical Sciences in Poznan, 60-535 Poznan, Poland.
Teresa Jackowska: Department of Pediatrics, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland. ORCID
Marcin Czech: Department of Pharmacoeconomics, Hospital Infection Control Team, Institute of Mother and Child, 01-211 Warsaw, Poland. ORCID
Ewa Helwich: Institute of Mother and Child, 01-211 Warsaw, Poland.
Oliver Martyn: Sanofi A/S, Vaccines Medical Affairs, DK-2100 K��benhavn, Denmark.
Pawel Aleksiejuk: Sanofi Sp. z o.o., Vaccines Medical Affairs, 01-211 Warsaw, Poland.
Anna Smaga: PEX Sp. z o.o., 02-796 Warsaw, Poland.
Joanna Glazewska: PEX Sp. z o.o., 02-796 Warsaw, Poland. ORCID
Jacek Wysocki: Department of Preventive Medicine, Poznan University of Medical Sciences at Poznan, 61-701 Poznan, Poland. ORCID
BACKGROUND: Respiratory syncytial virus (RSV) is an important cause of childhood hospitalizations. The aim of the study was to estimate the rates of RSV-related hospitalizations in children aged less than 5 years in Poland. METHODS: This retrospective observational cohort study was based on data obtained from the National Health Fund in Poland regarding all acute respiratory tract infections and RSV-coded admissions of children (age < 5 years) to public hospitals between July 2015 and June 2023. Patients were stratified based on the following age groups: 0-1 month, 2-3 months, 4-6 months, 7-12 months, 13-24 months, and 25-60 months. RESULTS: The number of RSV-related hospitalizations increased every season, both before and through the ending phase of the coronavirus disease 2019 (COVID-19) pandemic. The COVID-19 pandemic was associated with a shift in the seasonality pattern of RSV infection. Hospitalization rates per 1000 inhabitants were the highest for children aged 0-12 months, reaching 47.3 in the 2022/23 season. Within this group, the highest hospitalization rate was observed for children aged 2-3 months-94.9 in the 2022/23 season. During the ending phase of the COVID-19 pandemic, the observed increase in admission rates was 2-, 4-, and 5-fold the pre-COVID rate for children aged <12 months, 12-24 months, and 25-60 months, respectively. CONCLUSIONS: In Poland, RSV infections cause a significant burden in hospitalized children aged less than 5 years. RSV-related hospitalizations were most frequent in children aged less than 1 year. The COVID-19 pandemic was associated with a shift in the seasonality pattern of RSV infections. After the pandemic, more RSV-related hospitalizations were observed in older children (aged 13 months and older) vs. the pre-pandemic phase.
